Anodyne Nanotech
Phase 1Anodyne Nanotech is a clinical-stage biotech company, developing transdermal premium products for the treatment of chronic diseases.
Founded
2019
Focus
Drug Delivery
About
Anodyne Nanotech is a clinical-stage biotech company, developing transdermal premium products for the treatment of chronic diseases.
Funding History
2Total raised: $3.5M
Grant$250KNational Science FoundationMar 15, 2023
Seed$3.2MY CombinatorAug 15, 2022
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile